Cisplatin Plus Irinotecan In The Treatment Of Gallbladder Or Biliary Tract Cancer: A Randomized Phase Ii Trial (nct01859728).

dc.creatordos Santos
dc.creatorLV; Wagner
dc.creatorM; Ferraz
dc.creatorS; Lima
dc.creatorJP; Abdalla
dc.creatorKC
dc.date2016
dc.date2016-12-06T18:30:25Z
dc.date2016-12-06T18:30:25Z
dc.date.accessioned2018-03-29T02:03:00Z
dc.date.available2018-03-29T02:03:00Z
dc.identifier1527-7755
dc.identifierJournal Of Clinical Oncology. AMER SOC CLINICAL ONCOLOGY, n. 34, n. 4, p. .
dc.identifier0732-183X
dc.identifierWOS:000378109600467
dc.identifier
dc.identifierhttp://meetinglibrary.asco.org/content/160168-173
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/320032
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1310798
dc.description
dc.description34
dc.description
dc.description
dc.description
dc.descriptionGastrointestinal Cancers Symposium
dc.descriptionJAN 21-23, 2016
dc.descriptionSan Francisco, CA
dc.languageEnglish
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.publisherALEXANDRIA
dc.relationJournal of Clinical Oncology
dc.rightsembargo
dc.sourceWOS
dc.titleCisplatin Plus Irinotecan In The Treatment Of Gallbladder Or Biliary Tract Cancer: A Randomized Phase Ii Trial (nct01859728).
dc.typeResenha


Este ítem pertenece a la siguiente institución